These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25646956)

  • 1. Child immunisation is becoming unaffordable in some countries, charity warns.
    Gulland A
    BMJ; 2015 Jan; 350():h303. PubMed ID: 25646956
    [No Abstract]   [Full Text] [Related]  

  • 2. Children's charity criticises global immunisation initiative.
    Fleck F
    BMJ; 2002 Jan; 324(7330):129. PubMed ID: 11799019
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in global access to medicines threatened by funding shortfalls, warns charity.
    Moszynski P
    BMJ; 2011 Dec; 343():d8322. PubMed ID: 22205708
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of hepatitis B virus infection in the underprivileged world.
    Almasio PL; Craxì A
    Liver Int; 2011 Jul; 31(6):749-50. PubMed ID: 21645204
    [No Abstract]   [Full Text] [Related]  

  • 5. Can we use contingent valuation to assess the demand for childhood immunisation in developing countries?: a systematic review of the literature.
    Yeung RY; Smith RD
    Appl Health Econ Health Policy; 2005; 4(3):165-73. PubMed ID: 16309334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bounds of the concentration index when the variable of interest is binary, with an application to immunization inequality.
    Wagstaff A
    Health Econ; 2005 Apr; 14(4):429-32. PubMed ID: 15495147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunizing the world.
    Gates B; Gates M
    Newsweek; 2000 Dec; 136(26A):72-3. PubMed ID: 11147309
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunization initiatives.
    Levin JE; Giebink GS
    Minn Med; 1994 Feb; 77(2):17-20. PubMed ID: 8177174
    [No Abstract]   [Full Text] [Related]  

  • 9. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs of scaling up vaccination in the world's poorest countries.
    Bishai D; McQuestion M; Chaudhry R; Wigton A
    Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creating sustainable financing and support for immunization programs in fifteen developing countries.
    McQuestion M; Gnawali D; Kamara C; Kizza D; Mambu-Ma-Disu H; Mbwangue J; de Quadros C
    Health Aff (Millwood); 2011 Jun; 30(6):1134-40. PubMed ID: 21653967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poverty, wealth, and access to pandemic influenza vaccines.
    Yamada T
    N Engl J Med; 2009 Sep; 361(12):1129-31. PubMed ID: 19675324
    [No Abstract]   [Full Text] [Related]  

  • 13. Measles immunisation strategies to expand.
    Baleta A
    Lancet; 2003 Oct; 362(9393):1386. PubMed ID: 14594006
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunisation coverage in India remains too low, study finds.
    Travasso C
    BMJ; 2013 Sep; 347():f5573. PubMed ID: 24030790
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing financial barriers to vaccinating children and adolescents in the USA.
    Bednarczyk RA; Birkhead GS
    Curr Opin Pediatr; 2011 Feb; 23(1):105-9. PubMed ID: 21150447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult immunization: what can we learn from the childhood immunization program?
    Hinman AR; Orenstein WA
    Clin Infect Dis; 2007 Jun; 44(12):1532-5. PubMed ID: 17516394
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects and costs of expanding the coverage of immunisation services in developing countries: a systematic literature review.
    Pegurri E; Fox-Rushby JA; Damian W
    Vaccine; 2005 Feb; 23(13):1624-35. PubMed ID: 15694515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult immunization services: steps have to be done.
    Huot C; Sauvageau C; Tremblay G; Dubé E; Ouakki M
    Vaccine; 2010 Feb; 28(5):1177-80. PubMed ID: 19945413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. So far, so good.
    Conde C
    Tex Med; 2008 Mar; 104(3):37-42. PubMed ID: 18610872
    [No Abstract]   [Full Text] [Related]  

  • 20. Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
    Kaiser J
    Science; 2008 May; 320(5878):860. PubMed ID: 18487164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.